The first Health Canada-approved clinical trial for medical cannabis has started patient recruitment to determine the pain-relieving characteristics of vaporized cannabis.
The year-long Canadian study, which began patient recruitment June 23, 2015, is seeking participants aged 50 years or older who have primary osteoarthritis, or degenerative joint disease, of the knee. Patients will be considered if they are on a stable medication and treatment regimen, and not currently using cannabinoids.
The study is being funded by CanniMed Ltd., a wholly owned subsidiary of Saskatoon, Saskatchewan-based Prairie Plant Systems Inc. CanniMed is a licensed producer under Canada’s Marihuana for Medical Purposes Regulations, and its pharmaceutical-grade marijuana is produced under Good Manufacturing Practices regulations, the criteria used to manufacture all pharmaceuticals in Canada.
Prairie Plant Systems and CanniMed are teaming up with researchers at Canada’s McGill University Health Centre and Dalhousie Universities to offer
...
Follow us on Instagram
Connect with us on Linkedin